Dr. Gordon Ritchie received his Ph.D. in Experimental Medicine from the University of British Columbia (UBC) in 2001, following his BASc in Chemical Engineering from UBC in 1988. After completing his Ph.D., Dr. Ritchie established the first molecular reference laboratory at Sheikh Khalifa Medical City, operated by the Cleveland Clinic, in the United Arab Emirates, where he worked for six years. Since returning to Vancouver, he has served as the clinical molecular scientist at St. Paul’s Hospital, where he and his team have expanded the molecular diagnostics test menu by developing and validating various molecular tests, including PCR assays for viruses, bacteria, fungi, and antibiotic resistance. His research focuses on next-generation sequencing tests for viral genotyping, drug resistance, and bacterial identification.
Dr. Gordon Ritchie received his Ph.D. in Experimental Medicine from the University of British Columbia (UBC) in 2001, following his BASc in Chemical Engineering from UBC in 1988. After completing his Ph.D., Dr. Ritchie established the first molecular reference laboratory at Sheikh Khalifa Medical City, operated by the Cleveland Clinic, in the United Arab Emirates, where he worked for six years. Since returning to Vancouver, he has served as the clinical molecular scientist at St. Paul’s Hospital, where he and his team have expanded the molecular diagnostics test menu by developing and validating various molecular tests, including PCR assays for viruses, bacteria, fungi, and antibiotic resistance. His research focuses on next-generation sequencing tests for viral genotyping, drug resistance, and bacterial identification.